We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FDA Approves Teva's Pravachol After Court Dissolves Stay on Approvals
FDA Approves Teva's Pravachol After Court Dissolves Stay on Approvals
May 2, 2006
The FDA has granted final approval to Teva Pharmaceutical to market its version of Bristol-Myers Squibb’s cholesterol drug Pravachol, after a federal appeals court lifted the stay it had put on all FDA approvals to market versions of the drug.